Morphic Holding

Morphic Holding

World Rank (Jan-05-2024)
7,160
Market Cap (Jan-05-2024)
1.369 Billion USD
World Rank (Jul-30-2023)
4,888
Market Cap (Jul-30-2023)
2.536 Billion USD
World Rank (Jan-07-2022)
6,756
Market Cap (Jan-07-2022)
1.766 Billion USD
World Rank (Jan-01-2021)
7,794
Market Cap (Jan-01-2021)
1.038 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
MORF
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
71 Million USD
Annual Operating Income in USD
-63 Million USD
Annual Net Income in USD
-59 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
368 Million USD
Total Liabilities in USD
19 Million USD
Total Equity in USD
349 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
MORPHIC HOLDING
Yahoo
Yahoo @ Frankfurt
Company Profile
Morphic Holding is a Biopharmaceutical company leading the development of a new generation of oral integrin drugs and a unique integrin discovery platform. It is having 76 employees as on 2019. The headquarters is in USA.
Founded Year
2014
IPO Year
2019
Stock Exchange
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share